Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.

Saved in:
Bibliographic Details
Title: Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.
Authors: Strong, Randy1,2, Miller, Richard A.3, Antebi, Adam4, Astle, Clinton M.5, Bogue, Molly5, Denzel, Martin S.4, Fernandez, Elizabeth1,2, Flurkey, Kevin5, Hamilton, Karyn L.6, Lamming, Dudley W.7, Javors, Martin A.8, Magalhães, João Pedro9, Martinez, Paul Anthony1,2, McCord, Joe M.10, Miller, Benjamin F.6, Müller, Michael11, Nelson, James F.12, Ndukum, Juliet5, Rainger, G. Ed.13, Richardson, Arlan14,15
Source: Aging Cell. Oct2016, Vol. 15 Issue 5, p872-884. 13p.
Database: Academic Search Ultimate
Description
ISSN:14749718
DOI:10.1111/acel.12496